Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 128

Results For "Head"

1784 News Found

Lonza launches new non-endotoxin pyrogen detection system
News | June 07, 2022

Lonza launches new non-endotoxin pyrogen detection system

The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics


Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally
Healthcare | June 06, 2022

Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally

The rally attracted around 250 riders, including professionals and amateurs.


AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
People | June 04, 2022

AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK

AstraZeneca also played a critical role in the global response to COVID-19.


Susanne Kaestner and Thea Boehm join ProBioGen
People | June 04, 2022

Susanne Kaestner and Thea Boehm join ProBioGen

Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Innate Pharma announces IPH5201 phase 2 study in lung cancer
News | June 04, 2022

Innate Pharma announces IPH5201 phase 2 study in lung cancer

Innate to receive $5M milestone payment from AstraZeneca


LEO Pharma strengthens its commercial organization
News | June 03, 2022

LEO Pharma strengthens its commercial organization

The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally


Sanofi India appoints Preeti Futnani as GM, Vaccines
People | June 03, 2022

Sanofi India appoints Preeti Futnani as GM, Vaccines

Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.


Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
People | June 03, 2022

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead


Evonik to build new lipid production facility for mRNA-based therapies in U.S.
News | June 03, 2022

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025